New HIV vaccine with 97% antibody response rate shows promise in ‘landmark’ first-in-human trial
A novel vaccine approach for the prevention of HIV has shown promise in Phase I trials. IAVI and Scripps Research ...
A novel vaccine approach for the prevention of HIV has shown promise in Phase I trials. IAVI and Scripps Research ...
© 2022 WITHIN NIGERIA MEDIA LTD. designed by WebAndName
© 2022 WITHIN NIGERIA MEDIA LTD. designed by WebAndName